Skip to Main Content

Paper Details

Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.
Blood
62
2018
Author NameAffiliation
Claude PreudhommeCentre Hospitalier Regional Universitaire de Lille
Claude PreudhommeINSERM
Jean SoulierSaint-Louis Hospital
  • 1 - 3

Datasets

Release 1.2